Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Software
Data sources: ZENODO
addClaim

Analytic code, statistical analysis plan, and de-identified aggregate tables for a single-surgeon Versius versus da Vinci robot-assisted radical prostatectomy cohort study

Authors: Jobczyk, Mateusz; Clinton, Timothy N.; De Carvalho, Filipe L.; Ciechanowski, Piotr; Mouw, Kent W.; Fendler, Wojciech; Stawiski, Konrad;

Analytic code, statistical analysis plan, and de-identified aggregate tables for a single-surgeon Versius versus da Vinci robot-assisted radical prostatectomy cohort study

Abstract

Analytic R code, the frozen statistical analysis plan, the column data dictionary, the STROBE reporting checklist, the software environment manifest, and de-identified aggregate result tables underlying a retrospective single-surgeon cohort study comparing positive surgical margin (PSM) control between the Versius and da Vinci platforms in robot-assisted radical prostatectomy (704 consecutive cases, Poland, 2021-2026; external contextual calibration against a Brigham and Women's Hospital da Vinci multiport benchmark). The primary analysis is an era-clean, overlap-weighted propensity-score model estimating the average treatment effect in the overlap population on the absolute risk-difference scale. No individual patient-level data are included; the analytic master is held under controlled access subject to institutional approvals (Medical University of Lodz Bioethics Committee RNN/99/26/KE; Mass General Brigham IRB 2021P002957), data-use agreements, the Polish Personal Data Protection Act, and the EU General Data Protection Regulation. The aggregate tables and code are shared for transparency and reproducibility.

Powered by OpenAIRE graph
Found an issue? Give us feedback